Self-dosing is dangerous and can lead to serious side effects or a complete lack of results
J3420 billing for non-Medicare payers: Private insurance and Medicaid Medicares coverage rules for J3420 are the most thoroughly documented, but most practices see a mix of payers
Yehuda Handelsman: Received research grants, consultant and speaker honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Eli Lilly, Ionis, Merck, Novo Nordisk, Regeneron, Sanofi, Verdiva Bio
Taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms
Consider your skin type, sensitivity level, and specific concerns when making your choice